PPT-Disclaimer Rubella cases: Afghanistan

Total 59 cases Total 12 cases Total 47 cases Total 163 cases 2019 2020 2021 2022 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug. Susan E. Reef, MD. Global Measles and Rubella Management Meeting. March 15, 2011. Outline. Background. Terms of Reference. Opportunities to align with measles strategies. Recommendations from the WG. 10. th. Measles Initiative Meeting. September 13-14, 2011, . Washington DC. Susan. E. Reef, CDC/GID/DEEB. Peter M. Strebel, WHO/HQ/IVB/EPI. Outline. Global and regional status . CRS burden. Vaccine uptake and regional goals. Surveillance and Control . in . Low. -Resource Settings: . Limitations. , Biases, and . Potential . for Strengthening. Amy Winter, PhD Candidate, Princeton University. Advisor:. Jess Metcalf. Assistant Professor of Ecology and . --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. 10. th. Measles Initiative Meeting. September 13-14, 2011, . Washington DC. Susan. E. Reef, CDC/GID/DEEB. Peter M. Strebel, WHO/HQ/IVB/EPI. Outline. Global and regional status . CRS burden. Vaccine uptake and regional goals. Accelerating progress towards measles and rubella elimination. Geneva, Switzerland 21-23 June 2016 . Jenny Rota, WHO consultant. Goal is to update information to reflect current responsibilities of the network, provide best practices, resources and guidelines. Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. 2020. . Summary of the . Findings . and Implementation Status . Dr Kaushik . Banerjee. M&RI Partners' Meeting. Washington DC. 7 September 2017. 1. Objectives . of . the Review. To provide a candid review of progress . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Measles and Rubella Annual Partners Meeting, September 15-16 2015. Background. The MRI FRR is developed by the M&RI FRR/RMAWG. Country population data is drawn from UNDP estimates. Vaccine type and timing of SIAs is from countries . in . Low. -Resource Settings: . Limitations. , Biases, and . Potential . for Strengthening. Amy Winter, PhD Candidate, Princeton University. Advisor:. Jess Metcalf. Assistant Professor of Ecology and . Appendix 17 Date of Report: Month Day Year Date of last Evaluation of Infant: Month Day Year l PATIENT INFORMATION Child’s Name: La Opening Comments & Perspectives. Dr. Suresh Jadhav. Executive Director. Serum Institute of India Pvt. Ltd.,. ssj@seruminstitute.com. . We, at Serum Institute of India Pvt. Ltd., feel proud of being a partner to PAHO / WHO in achieving what is designated to be a historical achievement in eradication of Measles & Rubella diseases from the Americas.. Source. : ISIS, MESS and country reports. | . *Data as of 1 May 2023.. N=. 18,897. 20,064. 18,971. 13,009. 13,308. 41,663. 91,950. 25,693. 9,318. 14,927. Text. In the last 10 years, there was a downward trend in the notification rate of suspected measles and rubella cases, reaching its lowest point in 2021: .